Zibotentan Better Renal Scleroderma Outcome Study

NCT02047708 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Scleroderma
Scleroderma Renal Crisis
Chronic Kidney Disease

Interventions

DRUG: Zibotentan

Sponsor

University College, London

Collaborators

[object Object]